Charles River Laboratories Operating Margin 2010-2024 | CRL

Current and historical operating margin for Charles River Laboratories (CRL) over the last 10 years. The current operating profit margin for Charles River Laboratories as of June 30, 2024 is 13.10%.
Charles River Laboratories Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-06-30 $4.08B $0.56B 13.81%
2024-03-31 $4.11B $0.58B 14.01%
2023-12-31 $4.13B $0.62B 14.97%
2023-09-30 $4.22B $0.65B 15.39%
2023-06-30 $4.18B $0.65B 15.51%
2023-03-31 $4.09B $0.67B 16.38%
2022-12-31 $3.98B $0.65B 16.37%
2022-09-30 $3.78B $0.66B 17.46%
2022-06-30 $3.69B $0.67B 18.03%
2022-03-31 $3.63B $0.62B 16.97%
2021-12-31 $3.54B $0.59B 16.69%
2021-09-30 $3.43B $0.55B 15.96%
2021-06-30 $3.27B $0.52B 16.00%
2021-03-31 $3.04B $0.46B 15.22%
2020-12-31 $2.92B $0.43B 14.81%
2020-09-30 $2.82B $0.41B 14.62%
2020-06-30 $2.75B $0.37B 13.57%
2020-03-31 $2.72B $0.38B 13.80%
2019-12-31 $2.62B $0.35B 13.42%
2019-09-30 $2.53B $0.35B 13.62%
2019-06-30 $2.45B $0.34B 13.71%
2019-03-31 $2.38B $0.33B 14.01%
2018-12-31 $2.27B $0.33B 14.61%
2018-09-30 $2.14B $0.29B 13.63%
2018-06-30 $2.02B $0.28B 13.95%
2018-03-31 $1.91B $0.29B 15.07%
2017-12-31 $1.86B $0.29B 15.56%
2017-09-30 $1.85B $0.30B 15.98%
2017-06-30 $1.81B $0.28B 15.49%
2017-03-31 $1.77B $0.26B 14.44%
2016-12-31 $1.68B $0.24B 14.09%
2016-09-30 $1.57B $0.22B 14.02%
2016-06-30 $1.49B $0.22B 14.48%
2016-03-31 $1.40B $0.21B 15.31%
2015-12-31 $1.36B $0.21B 15.11%
2015-09-30 $1.34B $0.20B 14.56%
2015-06-30 $1.32B $0.19B 14.11%
2015-03-31 $1.32B $0.18B 13.72%
2014-12-31 $1.30B $0.18B 13.71%
2014-09-30 $1.26B $0.16B 12.89%
2014-06-30 $1.22B $0.16B 12.86%
2014-03-31 $1.17B $0.15B 12.70%
2013-12-31 $1.17B $0.15B 13.05%
2013-09-30 $1.16B $0.16B 14.01%
2013-06-30 $1.14B $0.16B 13.91%
2013-03-31 $1.14B $0.17B 14.54%
2012-12-31 $1.13B $0.17B 14.69%
2012-09-30 $1.14B $0.17B 15.16%
2012-06-30 $1.14B $0.17B 15.09%
2012-03-31 $1.14B $0.18B 15.40%
2011-12-31 $1.14B $0.17B 15.22%
2011-09-30 $1.13B $-0.23B -20.55%
2011-06-30 $1.13B $-0.26B -23.43%
2011-03-31 $1.13B $-0.29B -25.44%
2010-12-31 $1.13B $-0.30B -26.37%
2010-09-30 $1.12B $0.10B 9.05%
2010-06-30 $1.14B $0.14B 12.17%
2010-03-31 $1.16B $0.16B 13.78%
2009-12-31 $1.17B $0.17B 14.52%
Sector Industry Market Cap Revenue
Medical Medical Services $9.742B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00